Advertisement

Topics

Cmed Group Ltd Company Profile

03:34 EDT 26th September 2017 | BioPortfolio

Cmed was founded in 2000 by former senior pharmaceutical and clinical research executives with a vision of combining deep, full-spectrum experience in clinical services with innovative technology to provide customers a better way to manage clinical data. The Cmed Group includes Cmed (Clinical Research Services) Ltd, a full-service eCRO and Cmed Technology Ltd, an electronic data capture and management solutions company. Its diverse, global customers include pharmaceutical and biotechnology companies, academic institutions, CROs, and not-for-profit research organisations. It has its main office in Horsham, West Sussex UK, with additional offices in Timisoara, Romania; Murray Hill, NJ USA and Durham (Research Triangle Park), NC USA.


News Articles [617 Associated News Articles listed on BioPortfolio]

Cmed Shows How Encapsia Improves Patient Safety, Study Conduct And Decision Making At The Cmed Annual Meeting

  Life Sciences Jobs   ...

CanniMed Therapeutics Inc. (TSX: $CMED.V) Announces 2017 Third Quarter Results Release Date

SASKATOON, Saskatchewan - September 5, 2017 (Investorideas.com Newswire) CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed" or the "Company") announces that it plans to release its financial results fo...

Cmed Shows How encapsia® Provides Live, Actionable Data Insights in Oncology Clinical Trials at the 2017 ASCO Annual Meeting

Cmed, an innovative, technology-led oncology CRO, today announced it will be exhibiting at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinoi...

Cmed to present encapsia data at Mobile in Clinical Trials and D Pharm 2017 in Marriott Copley Place, Boston

Cmed, an innovative and full service technology─led CRO, announced it will present its encapsia clinical data suite at Mobile in Clinical Trials and D Pharm: Disruptive Innovations to Advance Clinic...

Cmed Leads Discussion on Improving Patient Safety Monitoring, Study Conduct and Decision Making in Oncology Clinical Trials at Clinical Operations in Oncology Trials East Coast

Thursday, June 29th 2017 at 2:00pm UTC DURHAM, N.C.–(BUSINESS WIRE)– Cmed, an innovative, technology-led oncology focused CRO, will present “Move towards more flexible and cost-effective...

Cmed Celebrates One Year Anniversary Of Encapsia

  Life Sciences Jobs   ...

Cmed Shows How encapsia® Improves Patient Safety, Study Conduct and Decision Making at the DIA Annual Meeting

Cmed, an innovative, technology-led oncology CRO, today announced its participation at the DIA Annual Meeting in Chicago, Illinois (June 19-21), where it will show how encapsia® ...

Cmed Leads Discussion on Improving Patient Safety Monitoring, Study Conduct and Decision Making in Oncology Clinical Trials at Clinical Operations in Oncology Trials East Coast

Cmed, an innovative, technology-led oncology focused CRO, will present “Move towards more flexible and cost-effective trials. The Power of Technology Driven Applications” at C...

PubMed Articles [2649 Associated PubMed Articles listed on BioPortfolio]

Core Mediator structure at 3.4 Å extends model of transcription initiation complex.

Mediator is a multiprotein co-activator that binds the transcription pre-initiation complex (PIC) and regulates RNA polymerase (Pol) II. The Mediator head and middle modules form the essential core Me...

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Protective effects of Tempol in an experimental ovarian ischemia-reperfusion injury model in female Wistar Albino rats.

The aim of this study was to investigate the antioxidant effects of tempol on ovarian ischemia-reperfusion injury in rats. Forty female Wistar albino rats were randomly divided into five groups: Group...

Effects of leptin on femoral fracture in rats.

In this study, our objective was to evaluate effects of leptin on fracture healing in rats. Seventy two male Sprague-Dawley (SD) rats were randomized into 3 groups. Standardized femoral fractures were...

Clinical Trials [3132 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Companies [1567 Associated Companies listed on BioPortfolio]

Cmed Inc

Cmed was founded by experienced industry professionals who shared a vision of solving the problems traditionally encountered in clinical trial data capture and management, by using new technology.Cmed...

Cmed Clinical Services

Cmed Clinical Services is a long-established, flexible CRO with offices in the UK, US and Romania offering project management, clinical monitoring, data management, biostatistics,...

Cmed Group Ltd

Cmed was founded in 2000 by former senior pharmaceutical and clinical research executives with a vision of combining deep, full-spectrum experience in clinical services with innov...

Cmed Technology

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

More Information about "Cmed Group Ltd" on BioPortfolio

We have published hundreds of Cmed Group Ltd news stories on BioPortfolio along with dozens of Cmed Group Ltd Clinical Trials and PubMed Articles about Cmed Group Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cmed Group Ltd Companies in our database. You can also find out about relevant Cmed Group Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record